Dean, Emma
Banerji, Udai
Schellens, Jan H. M.
Krebs, Matthew G.
Jimenez, Begona
van Brummelen, Emilie
Bailey, Chris
Casson, Ed
Cripps, Diana
Cullberg, Marie
Evans, Stephen
Foxley, Andrew
Lindemann, Justin
Rugman, Paul
Taylor, Nigel
Turner, Guy
Yates, James
Lawrence, Peter
Funding for this research was provided by:
AstraZeneca
Article History
Received: 4 October 2017
Accepted: 1 March 2018
First Online: 14 March 2018
Compliance with ethical standards
:
: Emma Dean has received institutional funding from AstraZeneca and is currently an employee of AstraZeneca. At the time of the study Emma Dean was employed by the Christie NHS Foundation Trust and the University of Manchester, Manchester, UK. Udai Banerji has received institutional funding from AstraZeneca, Onyx Pharmaceuticals, and Chugai and personal fees from Novartis and Astex. Chris Bailey, Ed Casson, Diana Cripps, Marie Cullberg, Stephen Evans, Andrew Foxley, Justin Lindemann, Paul Rugman, Nigel Taylor, Guy Turner, James Yates, and Peter Lawrence are, or were, employees of AstraZeneca at the time the study was conducted. All other authors have no conflicts of interest to disclose.
: Informed consent was obtained from all individual participants included in the study.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.